Posted today in New Drug Approvals

FDA Approves Benznidazole as First U.S. Treatment for Chagas Disease

The U.S. Food and Drug Administration today granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It is the first treatment approved in the United States for the treatment of Chagas disease. Chagas disease, or American trypanosomiasis, is a parasitic infection caused by Trypanosoma cruzi and can...

Posted today in Medical

Many U.S. Women Unaware of Fibroid Treatments: Poll

Many American women with uterine fibroids don't know there's a minimally invasive embolization technique that may be an alternative to a hysterectomy, a new poll finds. "Misperceptions about uterine fibroids and the treatments available often lead women to undergo invasive and potentially unnecessary surgery for their fibroids, despite more than 20...

Posted today in Medical

Many Parents Don't Tell Doctor About 'Complementary' Therapy Use in Kids

Parents often try unconventional treatments -- such as acupuncture and herbal products -- when their kids are sick, but many don't tell their pediatricians about it, a new report shows. Such omissions could be risky, especially when these young patients are already taking traditional medications, the report authors said. "The point we're making in...

Posted 2 days ago in New Drug Approvals

Faslodex (fulvestrant) Receives FDA Approval as Monotherapy for Expanded Use in HR+, HER2- Advanced Breast Cancer

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Faslodex (fulvestrant) 500mg as monotherapy for expanded use in women with hormone-receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer, who have gone through menopause and have not received previous endocrine...

Posted yesterday in New Drug Approvals

FDA Approves Cyltezo (adalimumab-adbm), a Biosimilar to Humira

Ridgefield, Conn., August 29, 2017 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Cyltezo, a biosimilar to Humira, in a pre-filled syringe for the treatment of multiple chronic inflammatory diseases, including: moderate to severe active rheumatoid arthritis moderate to severe...

Posted yesterday in Clinical Trials

FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo’s DS-8201 for HER2-Positive Metastatic Breast Cancer

Tokyo, Japan, Basking Ridge, NJ, and Munich, Germany – (August 29, 2017) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to DS-8201, an investigational HER2-targeting antibody drug conjugate (ADC), for the treatment of patients...

Posted today in Medical

Smoking Linked to Frailty in Seniors

Seniors who smoke may be more likely to become frail, a new British study suggests. Researchers tracked more than 2,500 people 60 and older in England and found that current smoking boosted that risk by about 60 percent. The scientists determined that the participants were frail if they had at least three of five conditions: unintentional weight loss,...

Posted today in Medical

Before Volcano Buried Pompeii, Toxic Water May Have Plagued Residents

Before a nearby volcano blew and buried the ancient Roman town of Pompeii centuries ago, residents were drinking toxic water that probably caused a host of ills, a new study suggests. Based on an analysis of pipes that ran through the city, Danish researchers believe that Pompeiians could have suffered from a variety of digestive problems and organ...

Posted today in Medical

Marriage a Blessing for Heart Attack Patients

Marriage is good medicine for someone who has a heart attack. That's the conclusion of a study that tracked nearly 1 million British patients for 13 years. The researchers found that married patients who had a heart attack were 14 percent more likely to survive until the end of the study than singles. And compared to divorced patients, survival odds...

Posted today in Medical

Diet Study Suggests It's Carbs, Not Fats, That Are Bad for You

A large, 18-country study may turn current nutritional thinking on its head. The new research suggests that it's not the fat in your diet that's raising your risk of premature death, it's too many carbohydrates -- especially the refined, processed kinds of carbs -- that may be the real killer. The research also found that eating fruits, vegetables...

Recently added consumer and prescribing information: Duzallo, Mavyret, Idhifa, Vosevi, Nerlynx, Tremfya, Bevyxxa, Rituxan Hycela, Baxdela, Imfinzi

Posted in Blog

Drugs.com Recognized as ‘Health Information Website Brand of the Year’ in 2017 Harris Poll EquiTrend® Study

The team at Drugs.com is humbled and heartened to have been recognized as the ‘Health Information Website Brand of the Year‘ in the 2017 Harris Poll EquiTrend Study. The annual Harris Poll EquiTrend® Study measures and compares a brand’s health over time and against key competitors. Other categories measured include travel, financial, automotive and entertainment. […]

Posted in Blog

REMS@FDA: An Upgraded Patient Safety Program

REMS Overview Fact: Prescription drugs are complicated, and they are getting more complicated every day. Issues with complex drugs and side effects is not just a concern for the healthcare provider, it directly impacts the patient and caregiver, too. We’ve all heard the long list of adverse effects and warnings that unfold during a primetime […]

Posted in Blog

Drugs.com the First Major Consumer Health Publisher to Implement Full HTTPS Encryption

Drugs.com is pleased to announce the introduction of full HTTPS encryption for all web site visitors. With this significant and important change, nearly 70 million monthly visitors will have access to critical health and medicine information in a safe, secure and private environment. Why HTTPS Encryption? Almost everything you do on the Internet leaves a digital […]